Pharmacokinetics of Cenobamate: Results From Single and Multiple Oral Ascending‐Dose Studies in Healthy Subjects
Author:
Affiliation:
1. SK Life Science, Inc. Paramus New Jersey USA
Funder
SK Life Science, Inc.
Publisher
Wiley
Subject
Pharmacology (medical),Pharmaceutical Science
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpdd.769
Reference26 articles.
1. Modern antiepileptic drug development has failed to deliver: Ways out of the current dilemma
2. Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs
3. Questioning the Effectiveness of Newer Antiseizure Medications
4. Antiepileptic drug combinations—Have newer agents altered clinical outcomes?
5. Patterns of treatment response in newly diagnosed epilepsy
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Panic disorder in epilepsy;Epilepsy & Behavior Reports;2024
2. Cenobamate as add-on therapy for drug resistant epilepsies: effectiveness, drug to drug interactions and neuropsychological impact. What have we learned from real word evidence?;Frontiers in Pharmacology;2023-12-21
3. Distribution, Metabolism, and Excretion of Cenobamate in Adult, Fetal, Neonatal, and Lactating Rats;European Journal of Drug Metabolism and Pharmacokinetics;2023-11-03
4. A New Antiseizure Medication: Cenobamate;Epilia: Epilepsy and Community;2023-09-30
5. Pharmacokinetics of cenobamate as monotherapy compared with adjunctive therapy;Epilepsy Research;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3